down arrow

U.S. Physical Therapy, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US90337L1089
USD
76.30
0.89 (1.18%)

Dec 04

NYS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

74.7576.30

52 Week

62.7799.35
Valuation
Technical
Day's Volume

CASH

34.06 k

Shareholding (Mar 2025)

FII

7.26%

Held by 84 FIIs

DII

45.26%

Held by 51 DIIs

Promoter

0.07%

How big is U.S. Physical Therapy, Inc.?

22-Jun-2025

As of Jun 18, U.S. Physical Therapy, Inc. has a market capitalization of $1.30 billion, with net sales of $699.46 million and a net profit of $47.62 million over the latest four quarters.

As of Jun 18, U.S. Physical Therapy, Inc. has a market capitalization of 1,295.91 million, categorizing it as a Small Cap company.<BR><BR>As of Jun 18, the company reported net sales of 699.46 million and a net profit of 47.62 million for the latest four quarters.<BR><BR>As of Dec 24, the reporting period shows shareholder's funds at 488.93 million and total assets amounting to 1,206.79 million.

Read More

What does U.S. Physical Therapy, Inc. do?

22-Jun-2025

U.S. Physical Therapy, Inc. operates outpatient physical therapy clinics and reported net sales of $184 million and a net profit of $13 million for Q1 2025. The company has a market capitalization of approximately $1.3 billion and key financial metrics include a P/E ratio of 28.00 and a dividend yield of 205.86%.

Overview:<BR>U.S. Physical Therapy, Inc. operates outpatient physical therapy clinics providing various rehabilitation services and belongs to the Pharmaceuticals & Biotechnology industry with a small-cap market capitalization.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: 184 Million (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: 13 Million (Quarterly Results - Mar 2025) <BR>Market-cap: USD 1,295.91 Million (Small Cap)<BR><BR>Key Metrics:<BR>P/E: 28.00 <BR>Dividend Yield: 205.86% <BR>Debt Equity: 0.34 <BR>Return on Equity: 9.58% <BR>Price to Book: 2.61 <BR><BR>Contact Details:<BR>Address: 1300 W Sam Houston Pkwy N Ste 300, HOUSTON TX: 77043-4011 <BR>Tel: 1 713 2977000 <BR>Website: https://www.usph.com/

Read More

Who are in the management team of U.S. Physical Therapy, Inc.?

22-Jun-2025

As of March 2022, the management team of U.S. Physical Therapy, Inc. includes Edward Kuntz (Independent Chairman), Christopher Reading (President and CEO), Reginald Swanson, Mark Brookner, Harry Chapman, Kathleen Gilmartin, and Bernard Harris (all Independent Directors). They oversee the company's operations and strategic direction.

As of March 2022, the management team of U.S. Physical Therapy, Inc. includes the following individuals:<BR><BR>- Mr. Edward Kuntz, who serves as the Independent Chairman of the Board.<BR>- Mr. Christopher Reading, who is the President, Chief Executive Officer, and a Director.<BR>- Mr. Reginald Swanson, who is a Director.<BR>- Mr. Mark Brookner, who is an Independent Director.<BR>- Mr. Harry Chapman, who is also an Independent Director.<BR>- Ms. Kathleen Gilmartin, who serves as an Independent Director.<BR>- Dr. Bernard Harris, who is another Independent Director.<BR><BR>This team is responsible for overseeing the company's operations and strategic direction.

Read More

Is U.S. Physical Therapy, Inc. overvalued or undervalued?

28-Oct-2025

As of October 24, 2025, U.S. Physical Therapy, Inc. is considered overvalued with a P/E ratio of 28 and has underperformed the S&P 500, achieving a 3-year return of 14.50% compared to the index's 78.85%.

As of 24 October 2025, the valuation grade for U.S. Physical Therapy, Inc. has moved from fair to expensive, indicating that the stock is overvalued. The company exhibits a P/E ratio of 28, a Price to Book Value of 2.70, and an EV to EBITDA of 17.32, all of which suggest a premium valuation compared to its peers. Notably, The Ensign Group, Inc. has a higher P/E of 32.46, while Option Care Health, Inc. is more attractively valued with a P/E of 23.61.<BR><BR>In terms of performance, U.S. Physical Therapy has underperformed against the S&P 500 over the longer term, with a 3-year return of 14.50% compared to the S&P 500's 78.85%. This underperformance, along with the high valuation ratios, reinforces the conclusion that the stock is overvalued.

Read More

Is U.S. Physical Therapy, Inc. technically bullish or bearish?

05-Nov-2025

As of October 31, 2025, U.S. Physical Therapy, Inc. shows a mildly bullish trend with mixed technical indicators and has underperformed the S&P 500, yielding a YTD return of -1.88% compared to 16.30% for the index.

As of 31 October 2025, the technical trend for U.S. Physical Therapy, Inc. has changed from bullish to mildly bullish. The weekly MACD is bullish, while the monthly MACD is mildly bullish. Bollinger Bands indicate a bullish stance for both weekly and monthly periods. However, the weekly KST is bullish, but the monthly KST is bearish, and Dow Theory shows a mildly bearish trend on the weekly timeframe. The daily moving averages are bullish. <BR><BR>In terms of performance, the stock has underperformed compared to the S&P 500 across multiple periods, with a YTD return of -1.88% versus 16.30% for the S&P 500, and a 5-year return of -1.71% compared to 109.18% for the index. Overall, the current stance is mildly bullish, but the strength is tempered by mixed signals and underperformance relative to the benchmark.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

High Management Efficiency with a high ROE of 16.16%

 
2

Strong ability to service debt as the company has a low Debt to EBITDA ratio of 1.36 times

 
3

Poor long term growth as Net Sales has grown by an annual rate of 10.85% and Operating profit at 7.40% over the last 5 years

 
4

The company has declared Positive results for the last 4 consecutive quarters

5

With ROE of 9.58%, it has a expensive valuation with a 2.70 Price to Book Value

6

Consistent Underperformance against the benchmark over the last 3 years

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

USD 1,477 Million (Small Cap)

stock-summary
P/E

28.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

181.62%

stock-summary
Debt Equity

0.33

stock-summary
Return on Equity

10.24%

stock-summary
Price to Book

2.95

Revenue and Profits:
Net Sales:
197 Million
(Quarterly Results - Jun 2025)
Net Profit:
19 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-11.08%
0%
-11.08%
6 Months
2.05%
0%
2.05%
1 Year
-23.63%
0%
-23.63%
2 Years
-13.07%
0%
-13.07%
3 Years
-16.07%
0%
-16.07%
4 Years
-13.91%
0%
-13.91%
5 Years
-30.07%
0%
-30.07%

U.S. Physical Therapy, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News

Is U.S. Physical Therapy, Inc. technically bullish or bearish?

As of 31 October 2025, the technical trend for U.S. Physical Therapy, Inc. has changed from bullish to mildly bullish. The weekly MACD is bullish, while the monthly MACD is mildly bullish. Bollinger Bands indicate a bullish stance for both weekly and monthly periods. However, the weekly KST is bullish, but the monthly KST is bearish, and Dow Theory shows a mildly bearish trend on the weekly timeframe. The daily moving averages are bullish. In terms of performance, the stock has underperformed compared to the S&P 500 across multiple periods, with a YTD return of -1.88% versus 16.30% for the S&P 500, and a 5-year return of -1.71% compared to 109.18% for the index. Overall, the current stance is mildly bullish, but the strength is tempered by mixed signals and underperformance relative to the benchmark....

Read More

Is U.S. Physical Therapy, Inc. technically bullish or bearish?

As of 31 October 2025, the technical trend for U.S. Physical Therapy, Inc. has changed from bullish to mildly bullish. The weekly MACD is bullish, while the monthly MACD is mildly bullish. The daily moving averages indicate a bullish stance, but the weekly Dow Theory shows a mildly bearish outlook. The Bollinger Bands present a mixed view, with weekly readings at mildly bullish and monthly at mildly bearish. Overall, the indicators suggest a mildly bullish sentiment, though there are some bearish signals in the longer-term metrics. In terms of performance, the stock has underperformed compared to the S&P 500 across multiple periods, with a year-to-date return of -2.01% versus the S&P 500's 16.30%, and a 1-year return of 6.82% compared to 19.89% for the benchmark....

Read More
U.S. Physical Therapy, Inc. Experiences Revision in Its Stock Evaluation Amid Market Dynamics

U.S. Physical Therapy, Inc. Experiences Revision in Its Stock Evaluation Amid Market Dynamics

U.S. Physical Therapy, Inc. has recently adjusted its valuation, with its stock price at $86.27. Over the past year, the company has seen a 7.60% return, lagging behind the S&P 500. Key metrics include a P/E ratio of 28 and a dividend yield of 198.40%, reflecting its financial standing in the sector.

Read More
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
10.85%
EBIT Growth (5y)
7.40%
EBIT to Interest (avg)
25.07
Debt to EBITDA (avg)
1.36
Net Debt to Equity (avg)
0.34
Sales to Capital Employed (avg)
0.96
Tax Ratio
24.42%
Dividend Payout Ratio
95.62%
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
14.64%
ROE (avg)
16.16%
Valuation key factors
Factor
Value
P/E Ratio
28
Industry P/E
Price to Book Value
2.70
EV to EBIT
22.62
EV to EBITDA
17.32
EV to Capital Employed
2.27
EV to Sales
2.16
PEG Ratio
NA
Dividend Yield
198.40%
ROCE (Latest)
10.06%
ROE (Latest)
9.58%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 66 Schemes (47.32%)

Foreign Institutions

Held by 84 Foreign Institutions (7.26%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 18.00% vs 10.36% in Jun 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 58.82% vs -23.72% in Jun 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "197.30",
          "val2": "167.20",
          "chgp": "18.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "30.60",
          "val2": "24.10",
          "chgp": "26.97%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "2.40",
          "val2": "2.00",
          "chgp": "20.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.10",
          "val2": "-4.30",
          "chgp": "102.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "18.90",
          "val2": "11.90",
          "chgp": "58.82%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "124.30%",
          "val2": "117.30%",
          "chgp": "0.70%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 11.00% vs 9.35% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 15.23% vs -8.33% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "671.30",
          "val2": "604.80",
          "chgp": "11.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "84.30",
          "val2": "85.30",
          "chgp": "-1.17%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "8.00",
          "val2": "9.30",
          "chgp": "-13.98%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-2.70",
          "val2": "-16.50",
          "chgp": "83.64%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "46.90",
          "val2": "40.70",
          "chgp": "15.23%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "97.80%",
          "val2": "115.00%",
          "chgp": "-1.72%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - YoYstock-summary
Jun'25
Jun'24
Change(%)
Net Sales
197.30
167.20
18.00%
Operating Profit (PBDIT) excl Other Income
30.60
24.10
26.97%
Interest
2.40
2.00
20.00%
Exceptional Items
0.10
-4.30
102.33%
Consolidate Net Profit
18.90
11.90
58.82%
Operating Profit Margin (Excl OI)
124.30%
117.30%
0.70%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in quarter ended Jun 2025 is 18.00% vs 10.36% in Jun 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Jun 2025 is 58.82% vs -23.72% in Jun 2024

All Quarterly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
671.30
604.80
11.00%
Operating Profit (PBDIT) excl Other Income
84.30
85.30
-1.17%
Interest
8.00
9.30
-13.98%
Exceptional Items
-2.70
-16.50
83.64%
Consolidate Net Profit
46.90
40.70
15.23%
Operating Profit Margin (Excl OI)
97.80%
115.00%
-1.72%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 11.00% vs 9.35% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 15.23% vs -8.33% in Dec 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About U.S. Physical Therapy, Inc. stock-summary
stock-summary
U.S. Physical Therapy, Inc.
Pharmaceuticals & Biotechnology
U.S. Physical Therapy, Inc., through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care, and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries. The Company's segment is made up of various clinics within partnerships. The Company primarily operates through subsidiary clinic partnerships, in which it owns a general partnership interest and a limited partnership interest, and the managing therapists of the clinics owns the remaining limited partnership interest in the clinics. The Company operates approximately 550 physical therapy clinics in 39 states. In addition to owning and operating clinics, the Company manages approximately 38 physical therapy facilities for unaffiliated third parties, including hospitals and physician groups.
Company Coordinates stock-summary
Company Details
1300 W Sam Houston Pkwy N Ste 300 , HOUSTON TX : 77043-4011
stock-summary
Tel: 1 713 2977000
stock-summary
https://www.usph.com/
stock-summary
Registrar Details
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."